Integrity Laboratories

Integrity Laboratories is a US-based, privately-held clinical diagnostics company that has evolved from its roots in toxicology and pharmacogenomics to become a leader in advanced infectious disease management. Its core mission is antimicrobial stewardship, enabled by its proprietary intercept PCR™ molecular diagnostics platform, which delivers rapid, high-fidelity results to guide targeted therapy. The company commercializes multiplex tests like RespiPlex AIO and leverages its genomIQ incubator to drive pipeline innovation, positioning itself at the intersection of value-based care and real-time diagnostic data.

intercept PCR™ molecular diagnostics platform: A proprietary platform enabling rapid, high-fidelity multiplex PCR testing with integrated data analytics. It focuses on non-invasive methods, polymicrobial differentiation, and provides a provider portal for actionable insights into antibiotic prescribing patterns and outcomes.

Integrity operates in the highly competitive clinical diagnostics market, facing large players like BioMérieux (BioFire), Roche, and Quest Diagnostics in infectious disease testing, and numerous labs in toxicology. It differentiates through its integrated data analytics for stewardship and its nimble, incubator-driven innovation model.